Sialyl-Tn-and neuron-specific enolase-positive minimally differentiated erythroleukemia

Internal Medicine

Volumn 39, Issue 10, 2000, Pages 843-846

  Muroi, Kazuo ^a   Tarumoto, Takahisa ^a   Akioka, Toshikazu ^a   Kirito, Keita ^a   Nagai, Tadashi ^a   Izumi, Tohru ^a   Nakamura, Mitsuru ^a   Hatake, Kiyohiko ^a   Hakomori, Sen Itiroh ^b   Miura, Yasusada ^a   Ozawa, Keiya ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

Carbohydrate; CD36; CFU E; Erythroblastic leukemia; M6; Tumor Marker

Indexed keywords

ENOLASE; LEUKOCYTE ANTIGEN; SIALOSYL TN ANTIGEN; SIALOSYL-TN ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BONE MARROW CELL; CASE REPORT; CELL DIFFERENTIATION; ERYTHROLEUKEMIA; FLOW CYTOMETRY; HUMAN; MALE; METABOLISM; MIDDLE AGED; NORTHERN BLOTTING; PATHOLOGY;

ANTIGENS, CD; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BLOTTING, NORTHERN; BONE MARROW CELLS; CELL DIFFERENTIATION; FLOW CYTOMETRY; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PHOSPHOPYRUVATE HYDRATASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034304279     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.843     Document Type: Article

References (14)

1. Villeval JL, Cramer P, Lemoine F, et al. Phenotype of early erythroblastic leukemias. Blood 68: 1167-1174, 1986.
2. Castaneda VL, Parmley RT, Saldivar VA, Cheah MS. Childhood undifferentiated leukemia with early erythroid markers and c-myb duplication. Leukemia 5: 142-149, 1991.
3. Garand R, Duchayne E, Blanchard D, et al. Minimally differentiated erythroleukaemia (AML M6 'variant'): a rare subset of AML distinct from AML M6. Br J Haematol 90: 868-875, 1995.
4. Ekert H, Sievers E, Tan A, et al. GATA-1 is expressed in acute erythroblastic leukaemia. Br J Haematol 86: 410-412, 1994.
5. Villamor N, Zarco MA, Rozman M, Ribera JM. Feliu E, Montserrat E. Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics. Leukemia 12: 1071-1075, 1998.
6. Muroi K, Suda T, Nakamura M, et al. Expression of sialosyl-Tn in colony-forming unit-erythroid, erythroblasts, B cells, and a subset of CD4+ cells. Blood 83: 84-91, 1994.
7. Muroi K, Amemiya Y, Sievers EL, Miura Y, Hakomori S, Loken MR. Expression of sialosyl-T and disialosyl-T antigens in erythroid cells. Leuk Lymphoma 25: 403-414, 1997.
8. Nagai T, Harigae H, Furuyama K, et al. 5-Aminolevulinate synthase expression and hemoglobin synthesis in a human myelogenous leukemia cell line. J Biochem (Tokyo) 121: 487-495, 1997.
9. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood 69: 255-263, 1987.
10. Nakahata T, Okumura N. Cell surface antigen expression in human erythroid progenitors: erythroid and megakaryocytic markers. Leuk Lymphoma 13: 401-409, 1994.
11. Baldus SE, Hanisch FG, Schwonzen M, et al. Monoclonal antibody SP-21 defines a sialosyl-Tn antigen expressed on carcinomas and K562 erythroleukemia cells. Anticancer Res 12: 1935-1940, 1992,
12. Brown KW, Kynoch PA, Thompson RJ. Immunoreactive nervous system of specific enolase (14-3-2 protein) in human serum and cerebrospinal fluid. Clin Chim Acta 101: 257-264, 1980.
13. Haimoto H, Takahashi Y, Koshikawa T, Nagura H, Kato K. Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab Invest 52: 257-263, 1985.
14. Cooper EH, Pritchard J, Bailey CC, Ninane J. Serum neuron-specific enolase in children's cancer. Br J Cancer 56: 65-67, 1987.